Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

Redirected T-Cell Killing of Solid Cancers Targeted with an Anti-CD3/Trop-2 Bispecific Antibody is Enhanced in Combination with Interferon-alpha.

Rossi EA, Rossi DL, Cardillo TM, Chang CH, Goldenberg DM.

Mol Cancer Ther. 2014 Jul 22. pii: molcanther.0345.2014. [Epub ahead of print]

PMID:
25053819
[PubMed - as supplied by publisher]
2.

SPECT- and Fluorescence Image-Guided Surgery Using a Dual-Labeled Carcinoembryonic Antigen-Targeting Antibody.

Rijpkema M, Oyen WJ, Bos D, Franssen GM, Goldenberg DM, Boerman OC.

J Nucl Med. 2014 Jun 30. pii: jnumed.114.142141. [Epub ahead of print]

PMID:
24982436
[PubMed - as supplied by publisher]
3.

Anti-CD22/CD20 Bispecific antibody with enhanced trogocytosis for treatment of Lupus.

Rossi EA, Chang CH, Goldenberg DM.

PLoS One. 2014 May 19;9(5):e98315. doi: 10.1371/journal.pone.0098315. eCollection 2014.

PMID:
24841238
[PubMed - in process]
Free PMC Article
4.

Al18F Labeling of Affibody Molecules.

McBride WJ, Goldenberg DM, Sharkey RM.

J Nucl Med. 2014 Apr 24;55(6):1043. [Epub ahead of print] No abstract available.

PMID:
24762625
[PubMed - as supplied by publisher]
5.

Trop-2-targeting tetrakis-ranpirnase has potent antitumor activity against triple-negative breast cancer.

Liu D, Cardillo TM, Wang Y, Rossi EA, Goldenberg DM, Chang CH.

Mol Cancer. 2014 Mar 10;13:53. doi: 10.1186/1476-4598-13-53.

PMID:
24606732
[PubMed - in process]
Free PMC Article
6.

A new class of bispecific antibodies to redirect T cells for cancer immunotherapy.

Rossi DL, Rossi EA, Cardillo TM, Goldenberg DM, Chang CH.

MAbs. 2014 Mar-Apr;6(2):381-91. doi: 10.4161/mabs.27385. Epub 2013 Dec 2.

PMID:
24492297
[PubMed - in process]
7.

Giant axon formation in mice lacking Kell, XK, or Kell and XK: animal models of McLeod neuroacanthocytosis syndrome.

Zhu X, Cho ES, Sha Q, Peng J, Oksov Y, Kam SY, Ho M, Walker RH, Lee S.

Am J Pathol. 2014 Mar;184(3):800-7. doi: 10.1016/j.ajpath.2013.11.013. Epub 2014 Jan 7.

PMID:
24405768
[PubMed - in process]
8.

Trogocytosis of multiple B-cell surface markers by CD22 targeting with epratuzumab.

Rossi EA, Goldenberg DM, Michel R, Rossi DL, Wallace DJ, Chang CH.

Blood. 2013 Oct 24;122(17):3020-9. doi: 10.1182/blood-2012-12-473744. Epub 2013 Jul 2.

PMID:
23821660
[PubMed - indexed for MEDLINE]
9.

Radiofluorination using aluminum-fluoride (Al18F).

McBride WJ, Sharkey RM, Goldenberg DM.

EJNMMI Res. 2013 May 8;3(1):36. doi: 10.1186/2191-219X-3-36.

PMID:
23651690
[PubMed]
Free PMC Article
10.

Targeting both IGF-1R and mTOR synergistically inhibits growth of renal cell carcinoma in vitro.

Cardillo TM, Trisal P, Arrojo R, Goldenberg DM, Chang CH.

BMC Cancer. 2013 Apr 1;13:170. doi: 10.1186/1471-2407-13-170.

PMID:
23548153
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Monoclonal antibodies targeting CD20.

Chang CH, Rossi EA, Goldenberg DM.

MAbs. 2013 May-Jun;5(3):335-6. doi: 10.4161/mabs.24106. Epub 2013 Mar 14. No abstract available.

PMID:
23493149
[PubMed - in process]
Free Article
12.

Milatuzumab-SN-38 conjugates for the treatment of CD74+ cancers.

Govindan SV, Cardillo TM, Sharkey RM, Tat F, Gold DV, Goldenberg DM.

Mol Cancer Ther. 2013 Jun;12(6):968-78. doi: 10.1158/1535-7163.MCT-12-1170. Epub 2013 Feb 20.

PMID:
23427296
[PubMed - indexed for MEDLINE]
Free Article
13.

Optimization of multivalent bispecific antibodies and immunocytokines with improved in vivo properties.

Rossi EA, Chang CH, Cardillo TM, Goldenberg DM.

Bioconjug Chem. 2013 Jan 16;24(1):63-71. doi: 10.1021/bc300488f. Epub 2012 Dec 21.

PMID:
23116517
[PubMed - indexed for MEDLINE]
14.

Evaluation of a novel hexavalent humanized anti-IGF-1R antibody and its bivalent parental IgG in diverse cancer cell lines.

Chang CH, Wang Y, Trisal P, Li R, Rossi DL, Nair A, Gupta P, Losman M, Cardillo TM, Rossi EA, Goldenberg DM.

PLoS One. 2012;7(8):e44235. doi: 10.1371/journal.pone.0044235. Epub 2012 Aug 31.

PMID:
22952934
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

A novel class of anti-HIV agents with multiple copies of enfuvirtide enhances inhibition of viral replication and cellular transmission in vitro.

Chang CH, Hinkula J, Loo M, Falkeborn T, Li R, Cardillo TM, Rossi EA, Goldenberg DM, Wahren B.

PLoS One. 2012;7(7):e41235. doi: 10.1371/journal.pone.0041235. Epub 2012 Jul 23.

PMID:
22844444
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Complex and defined biostructures with the dock-and-lock method.

Rossi EA, Goldenberg DM, Chang CH.

Trends Pharmacol Sci. 2012 Sep;33(9):474-81. doi: 10.1016/j.tips.2012.06.001. Epub 2012 Jun 26.

PMID:
22739259
[PubMed - indexed for MEDLINE]
17.

Pretargeted molecular imaging and radioimmunotherapy.

Goldenberg DM, Chang CH, Rossi EA, J W, McBride, Sharkey RM.

Theranostics. 2012;2(5):523-40. doi: 10.7150/thno.3582. Epub 2012 May 17.

PMID:
22737190
[PubMed]
Free PMC Article
18.

Designing immunoconjugates for cancer therapy.

Govindan SV, Goldenberg DM.

Expert Opin Biol Ther. 2012 Jul;12(7):873-90. doi: 10.1517/14712598.2012.685153. Review.

PMID:
22679911
[PubMed - indexed for MEDLINE]
19.

Validation of the BacT/ALERT(R) 3D System for Rapid Sterility Testing of Biopharmaceutical Samples.

Jimenez L, Rana N, Amalraj J, Walker K, Travers K.

PDA J Pharm Sci Technol. 2012 Jan-Feb;66(1):38-54. doi: 10.5731/pdajpst.2012.00790.

PMID:
22307661
[PubMed - in process]
20.

Molecular applications to pharmaceutical processes and cleanroom environments.

Jimenez L.

PDA J Pharm Sci Technol. 2011 May-Jun;65(3):242-53. doi: 10.5731/pdajpst.2011.00730.

PMID:
22293235
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk